Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (161-170 of 260) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Investigation|April 1, 1981
Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusionsS B Howell, B B Chu, W E Wung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Clinical pharmacokinetics of intraarterial cisplatin in humansT N Campbell, S B Howell, C E Pfeifle, et al.
Cancer Research|August 1, 1989
Dipyridamole enhancement of etoposide sensitivityS B Howell, D K Hom, R Sanga, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administrationP G Lindnér, D Heath, S B Howell, et al.
AJNR. American Journal of Neuroradiology|June 5, 1998
An organ-preserving selective arterial chemotherapy strategy for head and neck cancerC W Kerber, W H Wong, S B Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolitesA Fedier, M Schlamminger, V A Schwarz, et al.
Cancer Research|March 14, 2001
P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatinX Lin, K Ramamurthi, M Mishima, et al.
Seminars in Oncology|February 1, 1991
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinomaS B Howell, S Kirmani, E F McClay, et al.
Cancer Research|May 15, 1994
Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cellsA P Jekunen, D K Hom, J E Alcaraz, et al.
Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.
Pageof 26

Showing results (161-170 of 260) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Investigation|April 1, 1981
Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusionsS B Howell, B B Chu, W E Wung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Clinical pharmacokinetics of intraarterial cisplatin in humansT N Campbell, S B Howell, C E Pfeifle, et al.
Cancer Research|August 1, 1989
Dipyridamole enhancement of etoposide sensitivityS B Howell, D K Hom, R Sanga, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administrationP G Lindnér, D Heath, S B Howell, et al.
AJNR. American Journal of Neuroradiology|June 5, 1998
An organ-preserving selective arterial chemotherapy strategy for head and neck cancerC W Kerber, W H Wong, S B Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolitesA Fedier, M Schlamminger, V A Schwarz, et al.
Cancer Research|March 14, 2001
P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatinX Lin, K Ramamurthi, M Mishima, et al.
Seminars in Oncology|February 1, 1991
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinomaS B Howell, S Kirmani, E F McClay, et al.
Cancer Research|May 15, 1994
Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cellsA P Jekunen, D K Hom, J E Alcaraz, et al.
Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.
Pageof 26